T1	PROC 2004 2012	tratadas
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	PROC 56 69	Inmunoterapia
#2	AnnotatorNotes T2	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T3	CHEM 73 82	Nivolumab
#3	AnnotatorNotes T3	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T4	CHEM 105 129	medicamento experimental
#4	AnnotatorNotes T4	C0304229; Experimental drug; Pharmacologic Substance
T5	PROC 151 171	tratamiento estándar
#5	AnnotatorNotes T5	C2936643; Standard of Care; Health Care Activity
T6	DISO 201 250	carcinoma de células escamosas de cabeza y cuello
#6	AnnotatorNotes T6	C1168401; Squamous cell carcinoma of the head and neck; Neoplastic Process
T7	ANAT 448 465	células escamosas
#7	AnnotatorNotes T7	C0221910; Squamous Epithelial Cells; Cell
T8	ANAT 235 241	cabeza
#8	AnnotatorNotes T8	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T9	PROC 313 349	Ensayo aleatorizado, global, abierto
T10	CHEM 354 363	nivolumab
#9	AnnotatorNotes T10	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	DISO 435 484	carcinoma de células escamosas de cabeza y cuello
#10	AnnotatorNotes T11	C1168401; Squamous cell carcinoma of the head and neck; Neoplastic Process
T12	ANAT 469 475	cabeza
#11	AnnotatorNotes T12	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T13	ANAT 478 484	cuello
#12	AnnotatorNotes T13	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T14	DISO 548 573	Cáncer de Cabeza y Cuello
#13	AnnotatorNotes T14	C0278996; Malignant Head and Neck Neoplasm; Neoplastic Process
T15	DISO 600 649	Carcinoma de células escamosas de cabeza y cuello
#14	AnnotatorNotes T15	C1168401; Squamous cell carcinoma of the head and neck; Neoplastic Process
T16	ANAT 244 250	cuello
#15	AnnotatorNotes T16	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T17	DISO 2206 2211	basal
#16	AnnotatorNotes T17	C0751676; Basal Cell Cancer; Neoplastic Process
T18	ANAT 809 821	cavidad oral
#17	AnnotatorNotes T18	C0226896; Oral cavity; Body Space or Junction | C0230028; Oral region; Body Location or Region | C1267547; Entire mouth region; Body Space or Junction
T19	ANAT 823 833	orofaringe
#18	AnnotatorNotes T19	C0521367; Oropharyngeal; Body Location or Region | C1280659; Entire oropharynx; Body Part, Organ, or Organ Component
T20	ANAT 835 846	hipofaringe
#19	AnnotatorNotes T20	C0020629; hypopharynx; Body Location or Region | C1281332; Entire hypopharynx; Body Part, Organ, or Organ Component
T21	ANAT 849 856	laringe
#20	AnnotatorNotes T21	C0023078; Larynx; Body Part, Organ, or Organ Component | C1278904; Entire larynx; Body Part, Organ, or Organ Component
T22	DISO 861 871	Enfermedad
#21	AnnotatorNotes T22	C0012634; Disease; Disease or Syndrome
T23	PROC 901 912	tratamiento
#22	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	PROC 937 944	cirugía
#23	AnnotatorNotes T24	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T25	PROC 947 959	radioterapia
#24	AnnotatorNotes T25	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T26	PROC 970 983	quimioterapia
#25	AnnotatorNotes T26	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T27	PROC 996 1007	tratamiento
#26	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	PROC 1019 1047	terapia oncológica sistémica
T29	PROC 1131 1144	quimioterapia
#27	AnnotatorNotes T29	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T30	PROC 1157 1193	tratamiento adyuvante o neoadyuvante
T31	PROC 1213 1239	tratamiento multimodalidad
#28	AnnotatorNotes T31	C0871821; Multimodal Treatment Approach; Therapeutic or Preventive Procedure
T32	PROC 1241 1254	quimioterapia
#29	AnnotatorNotes T32	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T33	PROC 1257 1269	radioterapia
#30	AnnotatorNotes T33	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T34	DISO 1276 1286	enfermedad
#31	AnnotatorNotes T34	C0012634; Disease; Disease or Syndrome
T35	PROC 1317 1329	tratamientos
#32	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	DISO 1410 1437	progresión de la enfermedad
#33	AnnotatorNotes T36	C0242656; Disease Progression; Pathologic Function
T37	PROC 1493 1514	tratamiento sistémico
T38	DISO 1554 1572	Enfermedad medible
#34	AnnotatorNotes T38	C1513041; Measurable Disease; Disease or Syndrome
T39	CHEM 383 393	BMS-986205
#35	AnnotatorNotes T39	C4683552; BMS-986205; Immunologic Factor · Pharmacologic Substance
T40	PROC 1582 1585	MRI
#36	AnnotatorNotes T40	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T41	DISO 1690 1699	Carcinoma
#37	AnnotatorNotes T41	C0007097; Carcinoma; Neoplastic Process
T42	ANAT 1729 1740	nasofaringe
#38	AnnotatorNotes T42	C0027442; Nasopharynx; Body Part, Organ, or Organ Component | C1268975; Entire nasopharynx; Body Part, Organ, or Organ Component
T43	DISO 1742 1796	carcinoma de células escamosas de primario desconocido
#39	AnnotatorNotes T43	C0280097; Squamous Cell Carcinoma of Unknown Primary; Neoplastic Process
T44	DISO 1798 1828	carcinoma de células escamosas
#40	AnnotatorNotes T44	C0007137; Squamous cell carcinoma; Neoplastic Process
T45	ANAT 1850 1854	piel
#41	AnnotatorNotes T45	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T46	ANAT 1859 1875	glándula salivar
#42	AnnotatorNotes T46	C0036098; Salivary Glands; Body Part, Organ, or Organ Component | C1278917; Entire salivary gland; Body Part, Organ, or Organ Component
T47	ANAT 1881 1895	seno paranasal
#43	AnnotatorNotes T47	C0030471; Nasal sinus; Body Space or Junction | C1289341; Entire paranasal sinus cavity; Body Space or Junction
T48	ANAT 1912 1921	escamosas
#44	AnnotatorNotes T48	C0221909; Squamous epithelium; Tissue
T49	DISO 1931 1954	melanoma de las mucosas
T50	ANAT 2017 2020	SNC
#45	AnnotatorNotes T50	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T51	DISO 2039 2063	meningitis carcinomatosa
#46	AnnotatorNotes T51	C0220654; Meningeal Carcinomatosis; Neoplastic Process
T52	DISO 2133 2141	cánceres
#47	AnnotatorNotes T52	C0006826; Malignant Neoplasms; Neoplastic Process
T53	DISO 2214 2249	cáncer de piel de células escamosas
T54	ANAT 2232 2249	células escamosas
#48	AnnotatorNotes T54	C0221910; Squamous Epithelial Cells; Cell
T55	DISO 2251 2279	cáncer superficial de vejiga
T56	ANAT 2273 2279	vejiga
#49	AnnotatorNotes T56	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T57	DISO 2283 2339	carcinoma in situ de próstata, de cuello de útero o mama
T58	DISO 2066 2076	Malignidad
#50	AnnotatorNotes T58	C0006826; Malignant Neoplasms; Neoplastic Process
T59	ANAT 2317 2332	cuello de útero
T60	ANAT 2335 2339	mama
#51	AnnotatorNotes T60	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T61	PROC 179 194	régimen EXTREME
T62	DISO 263 274	metastásico
#52	AnnotatorNotes T62	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T63	PROC 404 428	régimen estándar EXTREME
T64	DISO 497 508	metastásico
#53	AnnotatorNotes T64	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T65	ANAT 558 564	Cabeza
#54	AnnotatorNotes T65	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T66	ANAT 567 573	Cuello
#55	AnnotatorNotes T66	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T67	ANAT 613 630	células escamosas
#56	AnnotatorNotes T67	C0221910; Squamous Epithelial Cells; Cell
T68	ANAT 634 640	cabeza
#57	AnnotatorNotes T68	C0018670; Head; Body Location or Region | C1281590; Entire head; Body Location or Region
T69	ANAT 643 649	cuello
#58	AnnotatorNotes T69	C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T70	DISO 661 672	metastásico
#59	AnnotatorNotes T70	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T71	ANAT 214 231	células escamosas
#60	AnnotatorNotes T71	C0221910; Squamous Epithelial Cells; Cell
T72	CHEM 130 140	BMS-986205
#61	AnnotatorNotes T72	C4683552; BMS-986205; Immunologic Factor · Pharmacologic Substance
T73	PROC 1577 1579	CT
#62	AnnotatorNotes T73	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T74	DISO 1714 1725	metastásico
#63	AnnotatorNotes T74	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T75	ANAT 1755 1772	células escamosas
#64	AnnotatorNotes T75	C0221910; Squamous Epithelial Cells; Cell
T76	ANAT 1811 1828	células escamosas
#65	AnnotatorNotes T76	C0221910; Squamous Epithelial Cells; Cell
T77	ANAT 1947 1954	mucosas
#66	AnnotatorNotes T77	C0026724; Mucous Membrane; Tissue | C1284117; Entire mucous membrane; Tissue
T78	DISO 1990 2000	metástasis
#67	AnnotatorNotes T78	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T79	ANAT 2224 2228	piel
#68	AnnotatorNotes T79	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T80	ANAT 2304 2312	próstata
#69	AnnotatorNotes T80	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T81	Date 13 17	2017
T83	Neg_cue 880 882	no
T85	Neg_cue 966 969	sin
T86	Neg_cue 989 995	Ningún
T87	Duration 1354 1363	> 6 meses
T88	Neg_cue 1395 1398	Sin
T89	Duration 1446 1462	al menos 6 meses
T91	LIVB 1641 1686	Mujeres embarazadas o en período de lactancia
#70	AnnotatorNotes T91	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T92	Neg_cue 1909 1911	no
T93	Neg_cue 1959 1969	Se excluye
T94	LIVB 1976 1985	pacientes
#71	AnnotatorNotes T94	C0030705; Patients; Patient or Disabled Group
T95	Neg_cue 2001 2003	no
T96	LIVB 2025 2034	Pacientes
#72	AnnotatorNotes T96	C0030705; Patients; Patient or Disabled Group
T97	Duration 2101 2119	los 3 años previos
T98	Neg_cue 2120 2127	excepto
T100	PHYS 1649 1660	embarazadas
#73	AnnotatorNotes T100	C0032961; Pregnancy; Organism Function
T101	PHYS 1677 1686	lactancia
#74	AnnotatorNotes T101	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T82	PROC 1519 1535	Estado funcional
#75	AnnotatorNotes T82	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T84	DISO 254 262	recidiva
#76	AnnotatorNotes T84	C2825055; Recurrence (disease attribute); Pathologic Function
T90	DISO 488 496	recidiva
#77	AnnotatorNotes T90	C2825055; Recurrence (disease attribute); Pathologic Function
T99	DISO 1703 1711	recidiva
#78	AnnotatorNotes T99	C2825055; Recurrence (disease attribute); Pathologic Function
T102	PROC 718 734	histológicamente
#79	AnnotatorNotes T102	C0344441; Histology Procedure; Laboratory Procedure
T103	PROC 1897 1908	histologías
#80	AnnotatorNotes T103	C0344441; Histology Procedure; Laboratory Procedure
T104	DISO 701 706	CCECC
#81	AnnotatorNotes T104	C1168401; Squamous cell carcinoma of the head and neck; Neoplastic Process
T105	DISO 1056 1061	CCECC
#82	AnnotatorNotes T105	C1168401; Squamous cell carcinoma of the head and neck; Neoplastic Process
T106	PROC 1374 1387	reclutamiento
#83	AnnotatorNotes T106	C0242800; Patient Recruitment; Research Activity
A1	Assertion T23 Negated
A2	Assertion T26 Negated
A3	Assertion T27 Negated
A4	Assertion T28 Negated
A5	Assertion T36 Negated
A6	Assertion T48 Negated
A7	Assertion T94 Negated
A8	Assertion T1 Negated
A9	Assertion T52 Negated
A10	Assertion T17 Negated
A11	Assertion T53 Negated
A12	Assertion T55 Negated
A13	Assertion T57 Negated
A14	Assertion T24 Negated
A15	Assertion T25 Negated
A16	Assertion T78 Negated
A17	Status T27 History_of
A18	Status T28 History_of
A19	Status T29 History_of
A20	Status T30 History_of
A21	Status T31 History_of
A22	Status T32 History_of
A23	Status T33 History_of
A24	Status T35 History_of
A25	Status T58 History_of
#84	AnnotatorNotes T30	C0600558; Neoadjuvant Therapy; Therapeutic or Preventive Procedure | C0677850; Adjuvant therapy; Therapeutic or Preventive Procedure
#85	AnnotatorNotes T49	C3898222; Mucosal Melanoma; Neoplastic Process 
#86	AnnotatorNotes T53	C0553723; Squamous cell carcinoma of skin; Neoplastic Process
#87	AnnotatorNotes T55	C1336527; Carcinoma of urinary bladder, superficial; Neoplastic Process
T107	Observation 1776 1784	primario
A26	Assertion T107 Speculated
T108	Spec_cue 1785 1796	desconocido
R1	Speculation Arg1:T108 Arg2:T107	
R2	Location_of Arg1:T50 Arg2:T78	
T109	Quantifier_or_Qualifier 2142 2161	localmente curables
A27	Assertion T109 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T109	
T110	Observation 2175 2196	aparentemente curados
A28	Assertion T110 Negated
R4	Negation Arg1:T98 Arg2:T52	
R5	Negation Arg1:T98 Arg2:T109	
R6	Negation Arg1:T98 Arg2:T110	
R7	Negation Arg1:T98 Arg2:T17	
R8	Negation Arg1:T98 Arg2:T53	
R9	Negation Arg1:T98 Arg2:T55	
R10	Negation Arg1:T98 Arg2:T57	
R11	Used_for Arg1:T3 Arg2:T2	
R12	Combined_with Arg1:T3 Arg2:T4	
R13	Combined_with Arg1:T3 Arg2:T72	
R15	Location_of Arg1:T71 Arg2:T6	
R16	Location_of Arg1:T8 Arg2:T6	
R17	Location_of Arg1:T16 Arg2:T6	
T111	Quantifier_or_Qualifier 275 291	en primera línea
R18	Combined_with Arg1:T10 Arg2:T39	
R19	Location_of Arg1:T7 Arg2:T11	
R20	Location_of Arg1:T12 Arg2:T11	
R21	Location_of Arg1:T13 Arg2:T11	
T112	Quantifier_or_Qualifier 509 525	en primera línea
R22	Location_of Arg1:T66 Arg2:T14	
R23	Location_of Arg1:T65 Arg2:T14	
R24	Location_of Arg1:T67 Arg2:T15	
R25	Location_of Arg1:T68 Arg2:T15	
R26	Location_of Arg1:T69 Arg2:T15	
T113	Observation 650 660	recurrente
#88	AnnotatorNotes T113	C0679254; Disease recurrence; Finding
R27	Before Arg1:T6 Arg2:T84	
R28	Before Arg1:T6 Arg2:T62	
R29	Before Arg1:T11 Arg2:T90	
R30	Before Arg1:T11 Arg2:T64	
R31	Before Arg1:T15 Arg2:T113	
R32	Before Arg1:T15 Arg2:T70	
R33	Location_of Arg1:T18 Arg2:T104	
R34	Location_of Arg1:T19 Arg2:T104	
R35	Location_of Arg1:T20 Arg2:T104	
R36	Location_of Arg1:T21 Arg2:T104	
R37	Negation Arg1:T83 Arg2:T23	
T114	Quantifier_or_Qualifier 913 935	con intención curativa
R38	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T114	
R39	Negation Arg1:T85 Arg2:T26	
R40	Negation Arg1:T83 Arg2:T24	
R41	Negation Arg1:T83 Arg2:T25	
R42	Negation Arg1:T86 Arg2:T27	
R43	Negation Arg1:T86 Arg2:T28	
R44	Combined_with Arg1:T32 Arg2:T33	
T115	Quantifier_or_Qualifier 1287 1306	localmente avanzada
R45	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T115	
R46	Has_Duration_or_Interval Arg1:T35 Arg2:T87	
R47	Before Arg1:T35 Arg2:T106	
R48	Negation Arg1:T88 Arg2:T36	
R49	Has_Duration_or_Interval Arg1:T36 Arg2:T89	
R50	After Arg1:T36 Arg2:T37	
T116	CONC 1540 1544	ECOG
#89	AnnotatorNotes T116	C1520224; ECOG performance status; Intellectual Product
R51	Used_for Arg1:T116 Arg2:T82	
T117	Result_or_Value 1548 1551	0-1
R52	Has_Result_or_Value Arg1:T116 Arg2:T117	
T118	CONC 1602 1612	RECIST 1.1
#90	AnnotatorNotes T118	C4086827; Response Evaluation Criteria in Solid Tumors Version 1.1; Intellectual Product)
R53	Experiences Arg1:T91 Arg2:T100	
R54	Experiences Arg1:T91 Arg2:T101	
R55	Before Arg1:T41 Arg2:T99	
R56	Before Arg1:T41 Arg2:T74	
R57	Location_of Arg1:T42 Arg2:T41	
R58	Location_of Arg1:T75 Arg2:T43	
R59	Location_of Arg1:T76 Arg2:T44	
R60	Location_of Arg1:T45 Arg2:T44	
R61	Location_of Arg1:T46 Arg2:T44	
R62	Location_of Arg1:T47 Arg2:T44	
R63	Negation Arg1:T92 Arg2:T48	
R64	Location_of Arg1:T77 Arg2:T49	
R65	Experiences Arg1:T96 Arg2:T51	
R66	Negation Arg1:T93 Arg2:T94	
R67	Negation Arg1:T93 Arg2:T78	
R68	Negation Arg1:T95 Arg2:T1	
R69	Experiences Arg1:T94 Arg2:T78	
R70	Experiences Arg1:T94 Arg2:T1	
T119	Quantifier_or_Qualifier 2084 2090	activa
#91	AnnotatorNotes T119	C0679217; Active State; Idea or Concept
R71	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T119	
R72	Has_Duration_or_Interval Arg1:T58 Arg2:T97	
R73	Before Arg1:T52 Arg2:T110	
R74	Location_of Arg1:T79 Arg2:T53	
R75	Location_of Arg1:T54 Arg2:T53	
R76	Location_of Arg1:T56 Arg2:T55	
R77	Location_of Arg1:T60 Arg2:T57	
R78	Location_of Arg1:T80 Arg2:T57	
R79	Location_of Arg1:T59 Arg2:T57	
R82	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T112	
R83	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T112	
R81	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T111	
R84	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T111	
T120	Quantifier_or_Qualifier 1344 1353	terminado
#92	AnnotatorNotes T120	C1272693; Ended - status; Qualitative Concept
R85	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T120	
R86	Overlap Arg1:T120 Arg2:T87	
R87	Before Arg1:T17 Arg2:T110	
R88	Before Arg1:T53 Arg2:T110	
R89	Before Arg1:T55 Arg2:T110	
T121	Quantifier_or_Qualifier 1909 1921	no escamosas
R98	Has_Quantifier_or_Qualifier Arg1:T103 Arg2:T121	
#93	AnnotatorNotes T37	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
#94	AnnotatorNotes T59	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
#95	AnnotatorNotes T57	C0154088; Carcinoma in situ of prostate; Neoplastic Process | C0851140; Carcinoma in situ of uterine cervix; Neoplastic Process | C0154084; Stage 0 Breast Carcinoma; Neoplastic Process 
R14	Before Arg1:T57 Arg2:T110	
#96	AnnotatorNotes T107	C0475447; Site of primary tumor; Finding
T122	Route 1038 1047	sistémica
R80	Has_Route_or_Mode Arg1:T28 Arg2:T122	
T123	Route 1505 1514	sistémico
R90	Has_Route_or_Mode Arg1:T37 Arg2:T123	
#97	AnnotatorNotes T122	C0205373; Systemic; Functional Concept
#98	AnnotatorNotes T123	C0205373; Systemic; Functional Concept
#99	AnnotatorNotes T114	C1880198; Cure (remedy); Conceptual Entity
A29	Experiencer T91 Patient
A30	Experiencer T94 Patient
A31	Experiencer T96 Patient
